Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines

D. Mahalingam, M. Keane, G. Pirianov, H. Mehmet, A. Samali, E. Szegezdi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis on binding to its receptors, death receptor 4 and 5 (DR4, DR5). TRAIL can also activate c-Jun N-terminal kinase (JNK) through the adaptor molecules, TNF receptor-associated factor 2 (TRAF2) and receptor-interacting protein (RIP). The role of JNK in TRAIL-induced tumour cell apoptosis is unclear. In this study, we demonstrate that JNK is activated by TRAIL in colon cancer cells. Inhibition of JNK with L-JNKI reduced rhTRAIL-induced cell death but enhanced cell death induced by selective activation of DR4 or DR5. This difference was unrelated to receptor internalisation or differential activation of c-Jun, but activation of different JNK isoforms. Our data demonstrate that JNK1, but not JNK2 is activated by rhTRAIL in the examined colon cancer cell lines. Although rhTRAIL activated both the long and short isoforms of JNK1, selective activation of DR4 or DR5 led to predominant activation of the short JNK1 isoforms (JNK1α1 and/or JNK1Β1). Knockdown of JNK1α1 by shRNA enhanced apoptosis induced by TRAIL, agonistic DR4 or DR5 antibodies. On the other hand, knockdown of the long JNK1 isoforms (JNK1α2 and JNK1Β2) had the opposite effect; it reduced TRAIL-induced cell death. These data indicate that the short JNK1 isoforms transmit an antiapoptotic signal, whereas the long isoforms (JNK1α2 or JNK1Β2) act in a proapoptotic manner.

Original languageEnglish (US)
Pages (from-to)1415-1424
Number of pages10
JournalBritish Journal of Cancer
Issue number9
StatePublished - May 5 2009


  • Apoptosis
  • C-Jun
  • Colon carcinoma
  • DR4
  • DR5
  • JNK1a1

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines'. Together they form a unique fingerprint.

Cite this